Genmab A/S
GMAB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $18,891,966 | $80,764,186 | $86,071,290 | $96,441,532 |
| - Cash | $1,761,000 | $8,212,778 | $8,212,778 | $9,858,000 |
| + Debt | $142,000 | $937,879 | $937,879 | $1,029,000 |
| Enterprise Value | $17,272,966 | $73,489,287 | $78,796,391 | $87,612,532 |
| Revenue | $1,022,000 | $5,861,744 | $715,000 | $6,441,000 |
| % Growth | -82.6% | 719.8% | -88.9% | – |
| Gross Profit | $964,000 | $5,500,533 | $673,000 | $6,104,000 |
| % Margin | 94.3% | 93.8% | 94.1% | 94.8% |
| EBITDA | $503,000 | $2,838,985 | $265,000 | $2,355,000 |
| % Margin | 49.2% | 48.4% | 37.1% | 36.6% |
| Net Income | $401,000 | $2,129,239 | $195,000 | $3,845,000 |
| % Margin | 39.2% | 36.3% | 27.3% | 59.7% |
| EPS Diluted | 0.65 | 3.42 | 0.31 | 5.99 |
| % Growth | -81% | 1,003.2% | -94.8% | – |
| Operating Cash Flow | $536,000 | $392,895 | $1,949,987 | $326,437 |
| Capital Expenditures | -$2,000 | -$63,370 | -$203,831 | -$26,986 |
| Free Cash Flow | $534,000 | $329,525 | $1,746,156 | $299,452 |